104 related articles for article (PubMed ID: 9835866)
1. Vinorelbine treatment of recurrent salivary gland carcinomas.
Airoldi M; Bumma C; Bertetto O; Gabriele P; Succo G; Pedani F
Bull Cancer; 1998 Oct; 85(10):892-4. PubMed ID: 9835866
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel and carboplatin for recurrent salivary gland malignancies.
Airoldi M; Fornari G; Pedani F; Marchionatti S; Gabriele P; Succo G; Bumma C
Anticancer Res; 2000; 20(5C):3781-3. PubMed ID: 11268454
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group.
Gilbert J; Li Y; Pinto HA; Jennings T; Kies MS; Silverman P; Forastiere AA
Head Neck; 2006 Mar; 28(3):197-204. PubMed ID: 16470745
[TBL] [Abstract][Full Text] [Related]
4. Lung metastasis resection of adenoid cystic carcinoma of salivary glands.
Bobbio A; Copelli C; Ampollini L; Bianchi B; Carbognani P; Bettati S; Sesenna E; Rusca M
Eur J Cardiothorac Surg; 2008 May; 33(5):790-3. PubMed ID: 18343149
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
[TBL] [Abstract][Full Text] [Related]
6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
7. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
8. Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies.
Airoldi M; Pedani F; Succo G; Gabriele AM; Ragona R; Marchionatti S; Bumma C
Cancer; 2001 Feb; 91(3):541-7. PubMed ID: 11169936
[TBL] [Abstract][Full Text] [Related]
9. The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland.
Chen AM; Garcia J; Bucci MK; Quivey JM; Eisele DW
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):138-43. PubMed ID: 17049183
[TBL] [Abstract][Full Text] [Related]
10. [Carcinoma of salivary glands--a clinical analysis of 342 cases].
Yu GY; Ma DQ
Zhonghua Zhong Liu Za Zhi; 1986 Sep; 8(5):395-8. PubMed ID: 3032547
[TBL] [Abstract][Full Text] [Related]
11. Malignant minor salivary gland tumors of the larynx.
Ganly I; Patel SG; Coleman M; Ghossein R; Carlson D; Shah JP
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):767-70. PubMed ID: 16847187
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group Study.
Muggia FM; Blessing JA; Waggoner S; Berek JS; Monk BJ; Sorosky J; Pearl ML
Gynecol Oncol; 2005 Jan; 96(1):108-11. PubMed ID: 15589588
[TBL] [Abstract][Full Text] [Related]
13. Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome.
Kazakov DV; Zelger B; Rütten A; Vazmitel M; Spagnolo DV; Kacerovska D; Vanecek T; Grossmann P; Sima R; Grayson W; Calonje E; Koren J; Mukensnabl P; Danis D; Michal M
Am J Surg Pathol; 2009 May; 33(5):705-19. PubMed ID: 19194280
[TBL] [Abstract][Full Text] [Related]
14. A Phase II trial of vinorelbine in patients with advanced gastroesophageal adenocarcinoma.
Kulke MH; Muzikansky A; Clark J; Enzinger PC; Fidias P; Kinsella K; Michelini A; Fuchs CS
Cancer Invest; 2006; 24(4):346-50. PubMed ID: 16777685
[TBL] [Abstract][Full Text] [Related]
15. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N
J BUON; 2007; 12(1):33-9. PubMed ID: 17436399
[TBL] [Abstract][Full Text] [Related]
16. [Adenoid cystic carcinoma of the head and neck: a review of 30 cases].
Raux-Rakotomalala F; Houliat T; Martel J; Stoll D; Bébéar JP; Darrouzet V
Rev Laryngol Otol Rhinol (Bord); 2003; 124(4):235-41. PubMed ID: 15038566
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of vinorelbine in recurrent and progressive epithelial ovarian cancer.
Burger RA; DiSaia PJ; Roberts JA; O'rourke M; Gershenson DM; Homesley HD; Lichtman SM; Barnes W; Moore DH; Monk BJ
Gynecol Oncol; 1999 Feb; 72(2):148-53. PubMed ID: 10021293
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.
Terhaard CH; Lubsen H; Van der Tweel I; Hilgers FJ; Eijkenboom WM; Marres HA; Tjho-Heslinga RE; de Jong JM; Roodenburg JL;
Head Neck; 2004 Aug; 26(8):681-92; discussion 692-3. PubMed ID: 15287035
[TBL] [Abstract][Full Text] [Related]
19. Malignant tumors of intraoral minor salivary glands.
Copelli C; Bianchi B; Ferrari S; Ferri A; Sesenna E
Oral Oncol; 2008 Jul; 44(7):658-63. PubMed ID: 17996484
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas.
Chen AM; Bucci MK; Quivey JM; Garcia J; Eisele DW; Fu KK
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1044-50. PubMed ID: 16965870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
